Ressing ME[Author] - Search Results

Year	Number of Results
1992	1
1994	1
1995	3
1996	4
1997	1
1998	1
1999	2
2000	1
2001	2
2003	2
2005	3
2006	2
2007	6
2008	5
2009	4
2010	4
2011	8
2012	6
2013	3
2014	4
2015	3
2016	1
2017	3
2020	3
2021	1
2022	0

1

Immune Evasion by Epstein-Barr Virus.

Ressing ME, van Gent M, Gram AM, Hooykaas MJ, Piersma SJ, Wiertz EJ. Ressing ME, et al. Curr Top Microbiol Immunol. 2015;391:355-81. doi: 10.1007/978-3-319-22834-1_12. Curr Top Microbiol Immunol. 2015. PMID: 26428381 Review.

2

Balancing STING in antimicrobial defense and autoinflammation.

Landman SL, Ressing ME, van der Veen AG. Landman SL, et al. Among authors: ressing me. Cytokine Growth Factor Rev. 2020 Oct;55:1-14. doi: 10.1016/j.cytogfr.2020.06.004. Epub 2020 Jun 6. Cytokine Growth Factor Rev. 2020. PMID: 32563552 Free article. Review.

3

Chemical Tools for Studying TLR Signaling Dynamics.

Oosenbrug T, van de Graaff MJ, Ressing ME, van Kasteren SI. Oosenbrug T, et al. Among authors: ressing me. Cell Chem Biol. 2017 Jul 20;24(7):801-812. doi: 10.1016/j.chembiol.2017.05.022. Epub 2017 Jun 22. Cell Chem Biol. 2017. PMID: 28648377 Free article. Review.

4

Inflammasomes and viruses: cellular defence versus viral offence.

Gram AM, Frenkel J, Ressing ME. Gram AM, et al. Among authors: ressing me. J Gen Virol. 2012 Oct;93(Pt 10):2063-2075. doi: 10.1099/vir.0.042978-0. Epub 2012 Jun 27. J Gen Virol. 2012. PMID: 22739062 Review.

5

Viral interference with antigen presentation: trapping TAP.

Ressing ME, Luteijn RD, Horst D, Wiertz EJ. Ressing ME, et al. Mol Immunol. 2013 Sep;55(2):139-42. doi: 10.1016/j.molimm.2012.10.009. Epub 2012 Nov 8. Mol Immunol. 2013. PMID: 23141382 Review.

6

Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands.

van de Graaff MJ, Oosenbrug T, Marqvorsen MHS, Nascimento CR, de Geus MAR, Manoury B, Ressing ME, van Kasteren SI. van de Graaff MJ, et al. Among authors: ressing me. Bioconjug Chem. 2020 Jun 17;31(6):1685-1692. doi: 10.1021/acs.bioconjchem.0c00237. Epub 2020 Jun 8. Bioconjug Chem. 2020. PMID: 32510940 Free PMC article.

7

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

Horst D, Ressing ME, Wiertz EJ. Horst D, et al. Among authors: ressing me. Immunol Cell Biol. 2011 Mar;89(3):359-66. doi: 10.1038/icb.2010.129. Epub 2011 Feb 8. Immunol Cell Biol. 2011. PMID: 21301483 Review.

8

Viral evasion of T cell immunity: ancient mechanisms offering new applications.

Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ. Horst D, et al. Among authors: ressing me. Curr Opin Immunol. 2011 Feb;23(1):96-103. doi: 10.1016/j.coi.2010.11.005. Epub 2010 Dec 9. Curr Opin Immunol. 2011. PMID: 21146386 Free article. Review.

9

A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.

Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, Croft NP, Neefjes JJ, Rickinson AB, Wiertz EJ. Hislop AD, et al. Among authors: ressing me. J Exp Med. 2007 Aug 6;204(8):1863-73. doi: 10.1084/jem.20070256. Epub 2007 Jul 9. J Exp Med. 2007. PMID: 17620360 Free PMC article.

10

Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Horst D, Geerdink RJ, Gram AM, Stoppelenburg AJ, Ressing ME. Horst D, et al. Among authors: ressing me. Viruses. 2012 Oct 23;4(10):2379-99. doi: 10.3390/v4102379. Viruses. 2012. PMID: 23202469 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results